about
Management of anticoagulant-related intracranial hemorrhage: an evidence-based review.Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis.Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study.Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage.Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review.Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherenceComparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocolThe practical management of intracerebral hemorrhage associated with oral anticoagulant therapy.Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.Intracerebral hemorrhage in patients receiving oral anticoagulation therapy.Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.The caregiver role in thromboprophylaxis management in atrial fibrillation: a literature review.The Severity of Intracranial Hemorrhages Measured by Free Hemoglobin in the Brain Depends on the Anticoagulant Class: Experimental Data.Effect of complexation with arabinogalactan on pharmacokinetics of "guest" drugs in rats: for example, warfarin.Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage.Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists
P2860
Q33750215-06EDBFB0-2892-4801-8561-D94FADDCD73EQ34132273-FAF8B590-D14B-4E2B-8513-7590B02A457FQ34513276-2823F44C-59E6-475B-A1FB-3DCDE35C68B2Q34986856-C1AB1730-E88F-45A4-A0BE-E1608DAADD4AQ35121230-23E9FE8D-C534-4966-A377-57127144401DQ36551541-A4342E73-334E-4281-9CD5-10A68C5E60E7Q37527133-544DFC85-CD81-4FEB-BE41-CD55084805E7Q37873969-9552ABF8-BF39-4E66-A2F8-0CC0852ED332Q38049617-2CE8A62F-D7D3-453D-9DE1-215ADF38C513Q38113483-B0CCF014-6192-479D-857E-5E1D29B60592Q38180538-ACA029A7-5E99-46CB-9A67-EC47C66B6C60Q38240097-54026AAE-34C1-4214-B8C2-6827E8B3F40FQ38624770-E8A33924-C731-4BAE-9FE0-544E5215BB8EQ41866030-6B797335-CA89-40C3-A91B-818CB64B6DE7Q48282136-BD9C617C-E877-4642-8895-5B9C64384B67Q58803005-8075C10D-28AD-473F-B15C-99024C4A6155
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Warfarin and intracranial haemorrhage.
@en
Warfarin and intracranial haemorrhage.
@nl
type
label
Warfarin and intracranial haemorrhage.
@en
Warfarin and intracranial haemorrhage.
@nl
prefLabel
Warfarin and intracranial haemorrhage.
@en
Warfarin and intracranial haemorrhage.
@nl
P1433
P1476
Warfarin and intracranial haemorrhage.
@en
P2093
Elfyn O Thomas
Rebecca Appelboam
P356
10.1016/J.BLRE.2008.05.001
P577
2008-06-25T00:00:00Z